中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
热门
The Lys103Asn mutation of HIV-1 RT: A novel mechanism of drug resistance

文献类型:期刊论文

作者Hsiou, Y; Ding, JP; Das, K; Clark, AD; Boyer, PL; Lewi, P; Janssen, PAJ; Kleim, JP; Rosner, M; Hughes, SH
刊名JOURNAL OF MOLECULAR BIOLOGY
出版日期2001
卷号309期号:2页码:437-445
关键词AIDS drug resistance HIV-1 reverse transcriptase non-nucleoside inhibitor X-ray crystallography
通讯作者Arnold, E (reprint author), Rutgers State Univ, Ctr Adv Biotechnol & Med, 679 Hoes Lane, Piscataway, NJ 08854 USA.,
英文摘要Inhibitors of human immunodeficiency virus (HIV) reverse transcriptase (RT) are widely used in the treatment of HIV infection. Loviride (an alpha -APA derivative) and HEY 097 (a quinoxaline derivative) are two potent non-nucleoside RT inhibitors (NNRTIs) that have been used in human clinical trials. A major problem for existing anti-retroviral therapy is the emergence of drug-resistant mutants with reduced susceptibility to the inhibitors. Amino acid residue 103 in the p66 subunit of HIV-1 RT is located near a putative entrance to a hydrophobic pocket that binds NNRTIs. Substitution of asparagine for lysine at position 103 of HIV-1 RT is associated with the development of resistance to NNRTIs; this mutation contributes to clinical failure of treatments employing NNRTIs. We have determined the structures of the unliganded form of the Lys103Asn mutant HIV-1 RT and in complexes with loviride and HEY 097. The structures of wild-type and Lys103Asn mutant HIV-1 RT in complexes with NNRTIs are quite similar overall as well as in the vicinity of the bound NNRTIs. Comparison of unliganded wild-type and Lys103Asn mutant HIV-1 RT structures reveals a network of hydrogen bonds in the Lys103Asn mutant that is not present in the wild-type enzyme. Hydrogen bonds in the unliganded Lys103Asn mutant but not in wild-type HIV-1 RT are observed between (1) the side-chains of Asn103 and Tyr188 and (2) well-ordered water molecules in the pocket and nearby pocket residues. The structural differences between unliganded wild-type and Lys103Asn mutant HIV-1 RT may correspond to stabilization of the closed-pocket form of the enzyme, which could interfere with the ability of inhibitors to bind to the enzyme. These results are consistent with kinetic data indicating that NNRTIs bind more slowly to Lys103Asn mutant than to wild-type HIV-1 RT. This novel drug-resistance mechanism explains the broad cross-resistance of Lys103Asn mutant HIV-1 RT to different classes of NNRTIs. Design of NNRTIs that make favorable interactions with the Asn103 side-chain should be relatively effective against the Lys103Asn drug-resistant mutant. (C) 2001 Academic Press.
学科主题Biochemistry & Molecular Biology
类目[WOS]Biochemistry & Molecular Biology
关键词[WOS]HUMAN-IMMUNODEFICIENCY-VIRUS ; TYPE-1 REVERSE-TRANSCRIPTASE ; ANTIBODY FAB FRAGMENT ; DOUBLE-STRANDED DNA ; ANGSTROM RESOLUTION ; NONNUCLEOSIDE INHIBITORS ; CONFORMATIONAL-CHANGES ; CRYSTAL-STRUCTURE ; HBY-097 ; COMPLEX
收录类别SCI
语种英语
WOS记录号WOS:000169266700008
版本出版稿
源URL[http://202.127.25.143/handle/331003/2602]  
专题上海生化细胞研究所_上海生科院生化细胞研究所
推荐引用方式
GB/T 7714
Hsiou, Y,Ding, JP,Das, K,et al. The Lys103Asn mutation of HIV-1 RT: A novel mechanism of drug resistance[J]. JOURNAL OF MOLECULAR BIOLOGY,2001,309(2):437-445.
APA Hsiou, Y.,Ding, JP.,Das, K.,Clark, AD.,Boyer, PL.,...&Arnold, E.(2001).The Lys103Asn mutation of HIV-1 RT: A novel mechanism of drug resistance.JOURNAL OF MOLECULAR BIOLOGY,309(2),437-445.
MLA Hsiou, Y,et al."The Lys103Asn mutation of HIV-1 RT: A novel mechanism of drug resistance".JOURNAL OF MOLECULAR BIOLOGY 309.2(2001):437-445.

入库方式: OAI收割

来源:上海生物化学与细胞生物学研究所

浏览0
下载0
收藏0
其他版本

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。